50
Participants
Start Date
November 20, 2017
Primary Completion Date
December 13, 2018
Study Completion Date
December 13, 2018
Cangrelor
Patients will be randomly assigned 1:1 to receive either cangrelor or matching placebo. The bolus will be administered at the same time of a 180 mg crushed ticagrelor loading dose and infusion will be continued for 2 h.
Placebo
Patients will be randomly assigned 1:1 to receive either cangrelor or matching placebo. The bolus will be administered at the same time of a 180 mg crushed ticagrelor loading dose and infusion will be continued for 2 h.
University of Florida, Jacksonville
Chiesi Farmaceutici S.p.A.
INDUSTRY
University of Florida
OTHER